Today we will deal with two special cases, Metlen and Cairo Mezz, and mezzanine bonds in general.
Now that everyone is short… it’s time to buy Metlen
Those who follow stock market developments will know that short positions in Metlen stock have increased. The share price of Metlen (formerly Mytilineos) stands at 34 to 35 euros with a market capitalization of 5 billion euros. A series of unfortunate events led the stock to 34–35 euros and triggered the opening of short positions. However, on the occasion of the Q1 2026 results to be announced on May 7, 2026—which will not contain full financial statements as the British Financial Conduct Authority does not require it—we can say the following. No more negative surprises from Metlen, no more reduction in profitability… 2026 will be a very strong year, and there should be no doubt. So now that everyone has gone short… the time has come for purchases in Metlen with a target of returning the stock to 38 euros initially and subsequently to 42 euros, which is perhaps its fair price.
What is happening with mezzanine bonds and Cairo Mezz?
Mezzanine bonds and traded shares like Cairo Mezz—and all similar instruments—have proven their riskiness to investors as highly toxic stock market products. Given that their collections are based on mezzanine and junior bonds, which are the lowest ranking in terms of seniority. While payments concern the senior bonds of the highest quality, which have been retained by the banks. The poor results of Cairo Mezz that were announced, showing losses of 92 million and an impairment of about 142 million in their fair value during the 2025 fiscal year, prove how dangerous and toxic these products are for minority shareholders who are easily misled.
www.bankingnews.gr
Σχόλια αναγνωστών